On the recordJune 11, 2018
This system is opaque, and the incentives are frequently perverse in drug pricing.
Source
congress.govEditor's note · Context
Collins discusses the complexities and issues in drug pricing systems.
Share & report
More from Susan Collins
Jun 10, 2025
It is leading to scientists leaving the United States for opportunities in other countries. It’s causing clinical trials to be halted and promising medical research to be abandoned.
Apr 28, 2025
The one thing that I would support are carefully crafted work requirements for able-bodied adults without preschool children.
May 5, 2025
I know that my constituents like knowing what the energy usage is of a particular appliance so that they can factor that into their buying decisions.
Other voices in this conversation
